And if you are AK, you just got $100K cash to use gaming the stock. If you're Mikey you just got 10% of the "grant monies" awarded to actually do anything.
All of which will be paid by retail stock holders in the next round of dilution.
"No reason"? Rotfl....A guaranteed new round of dilution within a year. Flat revenues that do not cover G&A, and need to increase at 30% a year for 5 years to meet that basic target.
Right now there's "No reason" for this dog to trade over $1.50 except for the buying by the corpsicle cult.
With what? BTX is on schedule to be broke by next March without another round of dilution....The ramp up for which got started by AK's old buddy--Cramer.
"because we will not be relying solely on stats review for efficacy" Correct: AST will be relying on the hype. In order for revenue to actually appear, only statistical significance is relevant. But to sell T-0stock, the hype is more relevant.
" assigning a 58mm valuation on the rest of BTX is probably a bit undervalued." And then subtract the $45mm burn rate, and the inflation in AST, and realise BTX is "probably a bit overvalued."
Without gross minus COG not able to cover 1/2 of G&A--a formula for death spiral dilution, anything over $2 is a "bit overvalued.". But it's time to raise money again, and so the gamesters are moving the price around....
"Weil Cornell is our lung PanC partner and rumored to announce " that it will keep taking BTX's money azs long as it is offered--along with anybody else who pays them.
"Patent"???? rotfl..... That's been off the table for 3 years. A product that is not a "me,too" might be useful. So far, there never has been one.
" never will be - just another shell in the game." Right. It's not a product, it's a utility. The product is T-shares.
" PanC DX (Tm) is not real." Sure it is. Just ask USPTO. Now, if it were "Coca-Cola" it might lead to EBITDA...but since it's Mikey.....when you pop the top you get a fizz of dilution.
At this point in the cycle, it's a signal to accumulate. When they start the "fever pitch" garbage, that's a distribute signal. The prudent speculator who likes this dawg can then end up with a few more shares at a basis like that of insiders and cronies---around1/8--plus get above mkt rates for the carry. At which point, mkt professionals and #$%$-sucking shorts will take their turn to make well above average RoR on the froth and trip back down towards 5x book---Currently well under $2.
" any major catalysts, nor the visionary leadership needed to convince the street to invest. BTX has had plenty of that. What is has failed to have at any time was a non-cultist, rubber meets the road mgt that is interested oin converting "vision" into revs over G&A, let alone GAAP net.
Each time the street realises this the price heads back towards what a 3 year plan will do to cash flows-- 1/2. Or 2x book--3/4. Or GAAP net, which would put this dog at $0.00 for a decade to come, minimum.
Name rings no bells, but OK--long time no chat. mesaone was not a boiler room agent, while cappy indeed ever so was hooked to houses, insiders and cronies doing one thing or another.
So: $4000, into around 100,000,000. Same as 4 into 100. Now, multiply by 4, and add in the filed data about the bekakda way BTX has always recorded Hextend revs.
Now--adjust for the reality that the Hextend patents are near expiry. And that in about 2010 the 10K said BTX was abandoning any and all R&D along those lines, which dooms the other "fluid" patents (There's around 10, dealing with dextrose)
Then the reality check--burn rate--can take center stage.
Then note that AK put the beginnings of a death spiral into the last tranche, and that burn + death spiral says that around the end of 2016 there will be another serious round of dilution, with no off-setting revs.
Nope. Hestend sales would support a price around 1/8. --- $0.125 for the newbies. The patent estate supports around 1 1/2.
So anything over 1.62 is, for the time being, the corspicle cult and hype.
(In a "bear mkt" for bio-bull, that patent estate drops to under 1 buck.)
"Not many shares to go around when this gets rolling." Lots of shares to get dumped onto the mkt any time BTX sees AST as overpriced---which will be constant process for years to some.
" Are any of these stem cell stock a home run waiting to happen?"
NO. Period. But they are all hyped in rotation as being the Next Big Thing, with BTX serving as the sinking mother ship of them all. After thorough DD, any of them them can be played cyclically, as rollers, and traded into accumulation.
Until it has operational revs - COG above G&A, it's going to keep trending (with hype fueled beta) towards 2-3X book--which according to BTX itself would be under 1 !/2. Hype can support 5X book---around 2.
The burn rate ensures Dilution, which will ensure oversupply of stock to the prudent mkt.
Hype will ensure occasional spikes to be fed to retail road kill.
Those dog&pony shows are for moving shelf stock, and mooving T-stock off the shelf at Garfies and AK.
Since BTX looks like it will need another major round of dilution around year's end, it is of course starting now at making its principle product since 1992, hype.